An Eye Scan to Find Early Signs of Alzheimer's Disease
Validation of Lens Beta-Amyloid as a Novel Biomarker for Early Detection of Alzheimer's Disease at the Boston University Alzheimer's Disease Research
This project is exploring if a special eye scanner can find early signs of Alzheimer's disease in the eye before memory problems begin.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11128554 on NIH RePORTER |
What this research studies
Alzheimer's disease often starts silently with changes in the brain long before memory issues appear. Currently, finding these early signs requires costly and sometimes uncomfortable brain scans or spinal fluid tests. This project is testing an innovative eye scanner, called Aftobetin-Sapphire II, which is designed to find early signs of Alzheimer's-related changes in the lens of your eye. Researchers believe these changes in the eye may show up even earlier than in the brain, offering a simpler way to detect the disease.
Who could benefit from this research
Good fit: This research is for individuals interested in early detection of Alzheimer's disease, particularly those who may be at risk but do not yet show cognitive symptoms.
Not a fit: Patients with advanced Alzheimer's disease or other non-Alzheimer's neurodegenerative conditions may not directly benefit from this early detection method.
Why it matters
Potential benefit: If successful, this could offer a simple, non-invasive eye scan to detect Alzheimer's disease much earlier, potentially allowing for earlier intervention.
How similar studies have performed: This project builds upon the researchers' own prior discoveries of Alzheimer's-related changes in the eye lens, making it an acceleration of a promising, novel approach.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Goldstein, Lee E. — Boston University Medical Campus
- Study coordinator: Goldstein, Lee E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.